3.58
3.58 (-0.88%)
As of Mar 06, 2024
Scisparc Ltd. [SPRC]
Source:
Company Overview
SciSparc’s proprietary compounds capitalize on the biochemistry of receptors that specialize in modulating the central nervous system to create therapeutics that mitigate the adverse symptoms associated with CNS disorders.
| Country | Israel |
| Headquarters | tel aviv |
| Phone Number | 972-3-6103100 |
| Industry | manufacturing |
| CEO | Oz Adler |
| Website | scisparc.com |